Hepatology (Baltimore, Md.)
Journal
Overview
publication venue for
-
Letter to the Editor: Serum identification of At-Risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
2024
-
Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis.
2024
-
Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis.
2024
-
Defining an approach for therapeutic strategies in metabolic dysfunction-associated steatotic liver disease after liver transplantation.
2023
-
Portable hypothermic oxygenated machine perfusion for organ preservation in liver transplantation (PILOTTM): A randomized, open-label, clinical trial.
2023
-
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.
2023
-
A global action agenda for turning the tide on fatty liver disease..
79.
2023
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)..
79.
2023
-
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study..
78.
2023
-
Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis..
79.
2023
-
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma..
77.
2023
-
The road to pandemic recovery: Tracking COVID-19's impact on cirrhosis care and outcomes among 111,558 Veterans..
77.
2023
-
Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis..
77.
2023
-
Examining the interim proposal for name change to steatotic liver disease in the US population..
77.
2023
-
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome..
77.
2023
-
The key role of hepatology providers in optimizing reproductive care in patients with liver disease: A call to action..
78.
2023
-
Genetic predisposition to porto-sinusoidal vascular disorder: a functional genomic-based, multi-generational family study.
2022
-
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis..
77.
2022
-
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH..
77.
2022
-
Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States..
76.
2022
-
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score..
76.
2022
-
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles..
76.
2022
-
S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells..
75.
2021
-
Intrahepatic cholangiocyte regeneration from an Fgf-dependent extrahepatic progenitor niche in a zebrafish model of Alagille Syndrome..
75.
2021
-
Hepatology Highlights..
74.
2021
-
Hepatology Highlights..
74.
2021
-
Hepatology Highlights..
74.
2021
-
Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States..
74.
2021
-
Hepatology Highlights..
74.
2021
-
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial..
74.
2021
-
Hepatology Highlights..
74.
2021
-
Black Patients With Cirrhosis Have Higher Mortality and Lower Transplant Rates: Results From a Metropolitan Cohort Study..
74.
2021
-
State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States..
74.
2021
-
Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health.
2021
-
Hepatology Highlights..
73.
2021
-
Hepatology Highlights..
73.
2021
-
Hepatology Highlights..
73.
2021
-
The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence.
2021
-
Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
2021
-
Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality..
73.
2021
-
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
2021
-
Hepatology Highlights..
73.
2021
-
From NAFLD to MAFLD: Implications of a Premature Change in Terminology..
73.
2021
-
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH..
73.
2021
-
Hepatology Highlights..
73.
2021
-
Hepatology Highlights..
73.
2021
-
Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience..
72.
2020
-
Hepatology Highlights..
72.
2020
-
Intestinal Virome in Patients With Alcoholic Hepatitis..
72.
2020
-
Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver..
72.
2020
-
Hepatology Highlights..
72.
2020
-
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial..
72.
2020
-
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement..
72.
2020
-
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience..
72.
2020
-
Hepatology Highlights..
71.
2020
-
Diet Associations With Nonalcoholic Fatty Liver Disease in an Ethnically Diverse Population: The Multiethnic Cohort..
71.
2020
-
Hepatology Highlights..
70.
2019
-
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis..
71.
2019
-
Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System..
71.
2019
-
Hepatology Highlights..
70.
2019
-
Hepatology Highlights..
70.
2019
-
Hepatology Highlights..
69.
2019
-
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis..
70.
2019
-
Hepatology Highlights..
69.
2019
-
Hepatology Highlights..
69.
2019
-
Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis..
70.
2019
-
Hepatology Highlights..
69.
2019
-
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial..
69.
2019
-
Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice..
69.
2019
-
Hepatology Highlights..
69.
2019
-
Activation of Pregnane X Receptor Sensitizes Mice to Hemorrhagic Shock-Induced Liver Injury.
70:995-1010.
2019
-
Hepatology Highlights..
69.
2019
-
Preemptive Activation of the Integrated Stress Response Protects Mice From Diet-Induced Obesity and Insulin Resistance by Fibroblast Growth Factor 21 Induction..
68.
2018
-
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection..
68.
2018
-
Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1-mediated p62/sequestosome 1 phosphorylation..
68.
2018
-
Viral persistence, liver disease, and host response in a hepatitis C-like virus rat model..
68.
2018
-
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study..
67.
2018
-
Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90..
67.
2018
-
A research agenda for curing chronic hepatitis B virus infection..
67.
2018
-
Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease..
67.
2017
-
An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice..
67.
2017
-
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study..
66.
2017
-
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patients..
66.
2017
-
Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells..
65.
2017
-
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice..
64.
2016
-
Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort..
64.
2016
-
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES..
64.
2016
-
Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice..
63.
2015
-
Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES..
62.
2015
-
Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B..
62.
2015
-
Microbial-derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells-derived and fetal hepatocytes..
62.
2015
-
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice..
62.
2015
-
Tumor-infiltrating, interleukin-33-producing effector-memory CD8(+) T cells in resected hepatocellular carcinoma prolong patient survival..
61.
2015
-
Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)..
61.
2015
-
Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt..
61.
2015
-
Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus..
61.
2015
-
Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment..
60.
2014
-
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response..
60.
2014
-
Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications..
60.
2014
-
Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection..
60.
2014
-
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents..
60.
2014
-
Human bile contains microRNA-laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis..
60.
2014
-
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study..
59.
2014
-
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy..
59.
2014
-
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource..
59.
2014
-
Steroid use in acute liver failure..
59.
2013
-
Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: a cause for concern..
59.
2013
-
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials..
58.
2013
-
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients..
58.
2013
-
Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis..
58.
2013
-
A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation..
57.
2013
-
Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?.
56.
2012
-
Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women..
56.
2012
-
Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma..
55.
2012
-
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo..
55.
2011
-
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells..
54.
2011
-
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures..
54.
2011
-
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients..
55.
2011
-
Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era..
54.
2011
-
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study..
54.
2011
-
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men..
54.
2011
-
Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice..
52.
2010
-
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma..
52.
2010
-
Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice..
51.
2010
-
Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury..
51.
2010
-
Effect of hepatitis C virus and its treatment on survival..
50.
2009
-
Targeting heat shock protein 90 with non-quinone inhibitors: a novel chemotherapeutic approach in human hepatocellular carcinoma..
50.
2009
-
Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells..
48.
2008
-
Clinical risk factors for portopulmonary hypertension..
48.
2008
-
Dendritic cells are required for effective cross-presentation in the murine liver..
47.
2008
-
Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate..
47.
2008
-
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis..
46.
2007
-
The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity..
46.
2007
-
Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1..
46.
2007
-
Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial..
46.
2007
-
Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C..
45.
2007
-
Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion..
45.
2007
-
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets..
45.
2007
-
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells..
43.
2006
-
Conventional liver CD4 T cells are functionally distinct and suppressed by environmental factors..
42.
2005
-
Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury..
41.
2005
-
A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse..
41.
2005
-
Wilson disease in septuagenarian siblings: Raising the bar for diagnosis..
41.
2005
-
Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection..
40.
2004
-
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees..
39.
2004
-
Prevalence of HBV precore/core promoter variants in the United States..
38.
2003
-
Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi..
33.
2001
-
Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer..
33.
2001
-
Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding..
31.
2000
-
Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival..
31.
2000
-
Decision-analysis of transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt for portal hypertension..
29.
1999
-
Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins..
28.
1998
-
Pharmacological expression in rat hepatocytes of a gene transferred by an adenovirus vector enabled by a chimeric promoter containing multiple cyclic adenosine monophosphate response elements..
27.
1998
-
Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat..
26.
1997
-
Transmembrane translocation of phosphatidylcholines and biliary lipid secretion: evidence for "flippases" in the canalicular plasma membrane..
24.
1996
-
Liver function in early Lyme disease..
23.
1996
-
Endoscopic therapy for cholangitis in cirrhosis..
23.
1996
-
Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 cases..
22.
1995
-
Rapid and efficient gene transfer in Human hepatocytes by herpes viral vectors..
22.
1995
-
Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: differing effects of cyclosporine and FK 506..
19.
1994
-
Coexpression of erythropoietin and heme oxygenase genes in Hep3B cells..
17.
1993
-
Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma..
16.
1992
-
The effect of liver denervation on hepatic hemodynamics during hypovolemic shock in swine..
15.
1992
-
Diet and cimetidine induce comparable changes in theophylline metabolism in normal subjects..
13.
1991
-
Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus-infected patients..
10.
1989
-
Pharmacokinetics of tin-mesoporphyrin in man and the effects of tin-chelated porphyrins on hyperexcretion of heme pathway precursors in patients with acute inducible porphyria..
9.
1989
-
Sn-protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects..
8.
1988
-
Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis..
8.
1988
-
The fluidity of liver plasma membranes from patients with different types of liver injury..
6.
1986
-
Functional properties of isolated hepatocytes from ethanol-treated rat liver..
5.
1985
-
Transmission of ground squirrel hepatitis virus to homologous and heterologous hosts..
5.
1985
-
Time course and mechanism of alterations in proton relaxation during liver regeneration in the rat..
5.
1985
-
Control of heme oxygenase and plasma levels of bilirubin by a synthetic heme analogue, tin-protoporphyrin..
4.
1984
-
Reply..
68.
2018
-
Reply..
64.
2016
-
Reply: To PMID 24954365..
62.
2015
-
Reply: To PMID 24954365..
61.
2015
-
Reply: To PMID 23929808..
60.
2014
-
Diagnostic utility of chromosome 17 and p16 abnormalities in fluorescence in situ hybridization tests in primary sclerosing cholangitis..
52.
2010
-
WIN-R revisited: Response to editorial..
47.
2008
-
Evasive maneuvers by hepatitis C virus..
38.
2003
-
Quality of life with pegylated interferon therapy for hepatitis C..
36.
2002
-
Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography..
29.
1999
-
Bacterial translocation in acute and chronic portal hypertension..
20.
1994
-
Driving Nonalcoholic Steatohepatitis Forward Using the FibroScan Aspartate Aminotransferase Score, But Obey the Traffic Lights.
2020
-
Reply: Machine learning models for NAFLD/NASH and cirrhosis diagnosis and staging: accuracy and routine variables are the success keys.
2023
-
Letter to the Editor: Pregnant Women and their Providers Want Direct-Acting Antivirals, and We Are Missing the Mark.
2021
-
Reply: To PMID 23703931.
2014
-
Blind beta blockade.
2001
-
Report of the Multisociety Task Force on GI training.
2009
-
ACE inhibitors: The secret to prevent cirrhosis complications and HCC in NAFLD?.
76.
2022
-
AASLD Educating and Engaging in the Digital Age: Editorial from Communications and Technology Committee.
2021
-
Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help Humans..
74.
2021
-
Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD..
68.
2018
-
Hepatology Highlights..
67.
2018
-
The patient's perspective in hepatitis C..
39.
2004
-
Multi-Disciplinary Clinic Models: A Paradigm of Care for Management of Non-Alcoholic Fatty Liver Disease (NAFLD).
2021
-
Thyroid Hormone Signaling and the Liver.
2020
-
A Call to Standardize Definitions, Data Collection, and Outcome Assessment to Improve Care in Alcohol-Related Liver Disease.
2019
-
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis.
2015
-
Hepatitis C and non-Hodgkin lymphoma: the clinical perspective.
2012
-
Sorafenib: where do we go from here?
2010
-
Is CD81 the key to hepatitis C virus entry?
1999
-
Placebo effect on progression and regression in NASH: Evidence from a meta-analysis.
2022
-
Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH: The State of the Art.
2021
-
HCV in Women and Pregnancy.
2019
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)